Why the study?
Does well-controlled maternal gestational diabetes affect the risk of cardiac hypertrophy and diastolic dysfunction in neonates?
Does well-controlled maternal gestational diabetes affect the risk of cardiac hypertrophy and diastolic dysfunction in neonates?
Glycemic control alone in gestational diabetes may be insufficient to prevent neonatal cardiac dysfunction, including hypertrophy and diastolic impairment.
May warrant neonatal cardiac evaluation in well-controlled GDM; leaves open whether intensified interventions prevent dysfunction.
It seems that neonates of mothers with well-controlled GDM are still at increased risk of cardiac hypertrophy, subclinical diastolic dysfunction, and impaired left ventricular relaxation. This can be interpreted that focusing only on glycemic control is not enough to prevent cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Ghandi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: